Literature DB >> 8859279

A U.S. epidemiologic survey of superficial fungal diseases.

M E Kemna1, B E Elewski.   

Abstract

BACKGROUND: Large-scale studies performed outside the United States have demonstrated that most cases of onychomycosis and tinea pedis are caused by dermatophytes, primarily Trichophyton rubrum. However, other studies have suggested that yeasts and nondermatophytic molds may play a role, particularly in onychomycosis.
OBJECTIVE: This study was undertaken to determine the epidemiology of superficial fungal infections in a U.S. population.
METHODS: Fungal cultures were performed on patients with clinically suspected tinea cruris, tinea corporis, tinea capitis, tinea pedis, and onychomycosis.
RESULTS: Dermatophytes were the most commonly isolated fungi in each type of superficial fungal disease studied. T. rubrum was the most commonly isolated dermatophyte species, although Trichophyton tonsurans was more common in tinea capitis and equally common in tinea corporis/tinea cruris. In tinea pedis and onychomycosis, dermatophytes appeared in approximately 95% and 82% of isolates, respectively. Candida albicans and nondermatophyte molds played only a minor role in onychomycosis; C. albicans was isolated in 7% of nail cultures and nondermatophytic molds were isolated in 11%.
CONCLUSION: These results are in general agreement with other major epidemiologic studies performed outside the United States. Dermatophyte fungi cause most superficial fungal infections.

Entities:  

Mesh:

Year:  1996        PMID: 8859279     DOI: 10.1016/s0190-9622(96)90675-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

1.  Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

Authors:  Pranab K Mukherjee; Steven D Leidich; Nancy Isham; Ingrid Leitner; Neil S Ryder; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  Wrestling mats: are they a source of ringworm infections?

Authors:  T D Kohl; D C Martin; R Nemeth; D L Evans
Journal:  J Athl Train       Date:  2000-10       Impact factor: 2.860

3.  A health-related quality of life measure for use in patients with onychomycosis: a validation study.

Authors:  D P Lubeck; D Gause; J R Schein; L E Prebil; L P Potter
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

4.  Rapid discrimination among dermatophytes, Scytalidium spp., and other fungi with a PCR-restriction fragment length polymorphism ribotyping method.

Authors:  M Machouart-Dubach; C Lacroix; M F de Chauvin ; I Le Gall ; C Giudicelli; F Lorenzo; F Derouin
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Tinea cruris epidemiology (São Paulo, Brazil).

Authors:  H Silva-Tavares; M M Alchorne; O Fischman
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 6.  Tinea gladiatorum: wrestling's emerging foe.

Authors:  T D Kohl; M Lisney
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

7.  Epidemiology of dermatophytoses in an area south of Tehran, Iran.

Authors:  Mehraban Falahati; Lame Akhlaghi; Abdolaziz Rastegar Lari; Reza Alaghehbandan
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

Review 8.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

9.  Nondermatophytic moulds as a causative agent of onychomycosis in tehran.

Authors:  Shahindokht Bassiri-Jahromi; Ali Asgar Khaksar
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

10.  Multicenter evaluation of a commercial PCR-enzyme-linked immunosorbent assay diagnostic kit (Onychodiag) for diagnosis of dermatophytic onychomycosis.

Authors:  C Savin; S Huck; C Rolland; M Benderdouche; O Faure; G Noacco; J Menotti; E Candolfi; H Pelloux; R Grillot; S Coupe; F Derouin
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.